HUP0401275A3 - C-2' methylated derivatives of paclitaxel for use as antitumor agents - Google Patents

C-2' methylated derivatives of paclitaxel for use as antitumor agents

Info

Publication number
HUP0401275A3
HUP0401275A3 HU0401275A HUP0401275A HUP0401275A3 HU P0401275 A3 HUP0401275 A3 HU P0401275A3 HU 0401275 A HU0401275 A HU 0401275A HU P0401275 A HUP0401275 A HU P0401275A HU P0401275 A3 HUP0401275 A3 HU P0401275A3
Authority
HU
Hungary
Prior art keywords
paclitaxel
antitumor agents
methylated derivatives
methylated
derivatives
Prior art date
Application number
HU0401275A
Other languages
English (en)
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of HUP0401275A2 publication Critical patent/HUP0401275A2/hu
Publication of HUP0401275A3 publication Critical patent/HUP0401275A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Compounds (AREA)
HU0401275A 2001-08-07 2002-07-23 C-2' methylated derivatives of paclitaxel for use as antitumor agents HUP0401275A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2001MI001734A ITMI20011734A1 (it) 2001-08-07 2001-08-07 Derivanti tassanici e procedimenti per la loro preparazione
PCT/EP2002/008185 WO2003013503A1 (en) 2001-08-07 2002-07-23 C-2' methylated derivatives of paclitaxel for use as antitumour agents

Publications (2)

Publication Number Publication Date
HUP0401275A2 HUP0401275A2 (hu) 2004-10-28
HUP0401275A3 true HUP0401275A3 (en) 2007-05-29

Family

ID=11448252

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0401275A HUP0401275A3 (en) 2001-08-07 2002-07-23 C-2' methylated derivatives of paclitaxel for use as antitumor agents

Country Status (21)

Country Link
US (1) US7153884B2 (hu)
EP (1) EP1423108B1 (hu)
KR (1) KR100894580B1 (hu)
CN (1) CN100370980C (hu)
AT (1) ATE363901T1 (hu)
AU (1) AU2002328942B2 (hu)
BR (1) BR0211770A (hu)
CA (1) CA2456523A1 (hu)
DE (1) DE60220524T2 (hu)
DK (1) DK1423108T3 (hu)
ES (1) ES2287310T3 (hu)
HK (1) HK1066483A1 (hu)
HU (1) HUP0401275A3 (hu)
IL (1) IL160233A0 (hu)
IT (1) ITMI20011734A1 (hu)
MX (1) MXPA04001234A (hu)
NO (1) NO20040535L (hu)
PL (1) PL194975B1 (hu)
PT (1) PT1423108E (hu)
RU (1) RU2287528C2 (hu)
WO (1) WO2003013503A1 (hu)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7816084B2 (en) * 2007-11-30 2010-10-19 Applied Genomics, Inc. TLE3 as a marker for chemotherapy
CN101851231A (zh) * 2010-05-27 2010-10-06 东北林业大学 一种多西紫杉醇新衍生物的合成方法及其在制备抗肿瘤药物中的应用
CN104650012A (zh) * 2013-11-22 2015-05-27 天士力控股集团有限公司 一种紫杉烷类化合物

Also Published As

Publication number Publication date
RU2287528C2 (ru) 2006-11-20
KR100894580B1 (ko) 2009-04-24
PL194975B1 (pl) 2007-07-31
CN100370980C (zh) 2008-02-27
PT1423108E (pt) 2007-08-28
PL367868A1 (en) 2005-03-07
DE60220524D1 (de) 2007-07-19
RU2004103481A (ru) 2005-06-10
ATE363901T1 (de) 2007-06-15
US20040242674A1 (en) 2004-12-02
EP1423108A1 (en) 2004-06-02
CA2456523A1 (en) 2003-02-20
US7153884B2 (en) 2006-12-26
IL160233A0 (en) 2004-07-25
DE60220524T2 (de) 2008-02-07
AU2002328942B2 (en) 2007-08-30
HUP0401275A2 (hu) 2004-10-28
ES2287310T3 (es) 2007-12-16
KR20040030926A (ko) 2004-04-09
EP1423108B1 (en) 2007-06-06
WO2003013503A1 (en) 2003-02-20
CN1538841A (zh) 2004-10-20
MXPA04001234A (es) 2004-05-27
NO20040535L (no) 2004-04-26
BR0211770A (pt) 2004-07-27
HK1066483A1 (en) 2005-03-24
ITMI20011734A1 (it) 2003-02-07
ITMI20011734A0 (it) 2001-08-07
DK1423108T3 (da) 2007-10-01

Similar Documents

Publication Publication Date Title
FR20C1039I2 (fr) Derives de l'uk-2a
HK1066218A1 (en) Qunazoline derivatives as antitumor agents
HK1065801A1 (en) Quinazoline derivatives as antitumor agents
HK1068337A1 (en) Thiopene- amd thiazolesulfonamides as antineoplastic agents
HK1060875A1 (en) Tetralone derivatives as antitumor agents
IL146100A0 (en) 4,5,6,7-tetrahydroindazole derivatives as antitumor agents
IL161881A (en) N,n'-substituted-1,3-diamino-2- hydroxypropane derivatives
HUP0401642A3 (en) Use of staurosporine derivatives for the preparation of pharmaceutical compositions
HUP0400114A3 (en) N-benzoyl-benzenesulfonamid derivatives as antitumor agents and pharmaceutical compositions containing them
AU2001252463A1 (en) Thiophene derivatives useful as anticancer agents
IL161372A0 (en) Crystalline solvates of paclitaxel
IL156988A0 (en) Pharmaceutical compositions containing epothilone derivatives
IL157128A0 (en) Pharmaceutical compositions containing epothilone derivatives
HK1041482B (zh) 作為細胞毒性抗腫瘤劑的萘並噻吩和二氫苯並噻吩的衍生物
IL157889A0 (en) Substituted benzofuran-2-carboxamide derivatives
HUP0303186A3 (en) 4-aminobenzopyran derivatives
AU2003214609A8 (en) Derivatives of isoflavones
GB2374940B (en) "Surveying of boreholes"
HUP0401275A3 (en) C-2' methylated derivatives of paclitaxel for use as antitumor agents
AU2001214116A1 (en) Novel paclitaxel derivatives for the treatment of cancer
EP1364954A4 (en) Dicarba closo DODECARBORANDERIVATE
SI1423108T1 (sl) C-2'-metilirani derivati paklitaksela za uporabo kot antitumorska sredstva
HUP0200752A3 (en) C7 carbamoyloxy substituted taxanes as antitumor agents
HK1053059A1 (zh) 新用途
AU2003265482A8 (en) Non-nucleosidic coumarin derivatives as polynucleotide-crosslinking agents

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees